OABI — OmniAb, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2018-12-17.
Performance
Technicals
Others in Healthcare
Measured signals that fired on OABI
| date | signal | measured base rate |
|---|---|---|
| 2026-08-17 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-04-07 | Cluster sale: three or more insiders insider | -0.37% over 21 days · t = -3.38 · n = 21,542 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-06-17 | Gotwals Philip J Director | Option exercise | 20.0K | — | — |
| 2026-06-17 | Bertozzi Carolyn R Director | Option exercise | 20.0K | — | — |
| 2026-06-17 | HIGGINS JOHN L Director | Option exercise | 20.0K | — | — |
| 2026-06-17 | Cochran Jennifer R. Director | Option exercise | 20.0K | — | — |
| 2026-06-17 | Love Steven Director | Option exercise | 20.0K | — | — |
| 2026-06-17 | Crouse Steven C. Director | Option exercise | 20.0K | — | — |
| 2026-04-21 | Crouse Steven C. Director | Option exercise | 13.3K | — | — |
| 2026-04-21 | Gotwals Philip J Director | Option exercise | 13.3K | — | — |
| 2026-04-07 | FOEHR MATTHEW W President and CEO | Open-market sale | 19.2K | 1.49 | 28.7K |
| 2026-04-07 | Berkman Charles S Chief Legal Officer | Open-market sale | 7.2K | 1.49 | 10.7K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Whitefort Capital Management, LP | 22.3M | 14.2M |
| BlackRock, Inc. | 12.7M | 8.1M |
| CADIAN CAPITAL MANAGEMENT, LP | 6.5M | 4.2M |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.3M | 4.0M |
| GEODE CAPITAL MANAGEMENT, LLC | 4.6M | 2.9M |
| RICE HALL JAMES & ASSOCIATES, LLC | 4.0M | 2.5M |
| PRIVATE MANAGEMENT GROUP INC | 3.8M | 2.4M |
| STATE STREET CORP | 3.2M | 2.1M |
| DIMENSIONAL FUND ADVISORS LP | 2.7M | 1.7M |
| TOWERVIEW LLC | 1.6M | 1.0M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-14 | — | on EDGAR ↗ |
| 10-Q | 2026-08-06 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-06 | 2026-08-06 | on EDGAR ↗ |
| 4 | 2026-08-03 | 2026-08-01 | on EDGAR ↗ |
| 3 | 2026-07-13 | 2026-07-13 | on EDGAR ↗ |
| 8-K | 2026-07-13 | 2026-07-13 | on EDGAR ↗ |
| 4 | 2026-06-18 | 2026-06-17 | on EDGAR ↗ |
| 4 | 2026-06-18 | 2026-06-17 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Why Is Omniab Stock Rallying After Eli Lilly Deal? · 2026-08-17 · benzinga
- OmniAb Announces Global Collaboration and License Agreement with Eli Lilly For New Ion Channel Program; OmniAb To Receive An Upfront Payment and Is Eligible To Receive Up to $370M In R&D and Commercial Milestone Payments · 2026-08-17 · benzinga
- Natera, Doximity, PubMatic, Airbnb And Other Big Stocks Moving Higher On Friday · 2026-08-07 · benzinga
Ask the AI about OABI
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →